You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Profile for Australia Patent: 2024227714


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2024227714

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial May 22, 2034 Botanix Sb SOFDRA sofpironium bromide
⤷  Start Trial May 22, 2034 Botanix Sb SOFDRA sofpironium bromide
⤷  Start Trial May 22, 2034 Botanix Sb SOFDRA sofpironium bromide
⤷  Start Trial May 22, 2034 Botanix Sb SOFDRA sofpironium bromide
⤷  Start Trial May 22, 2034 Botanix Sb SOFDRA sofpironium bromide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent AU2024227714: Scope, Claims, and Patent Landscape

Last updated: February 21, 2026

What is the scope of AU2024227714?

Patent AU2024227714 claims protection for a pharmaceutical invention related to [specific drug or therapeutic application], filed by [applicant or assignee], with priority date [date]. The patent's scope primarily covers:

  • The formulation comprising [active ingredient(s)] at specified concentrations.
  • Specific methods of manufacturing or preparing the formulation.
  • Novel uses or methods of administration for treatment of [indicated condition].

The claims aim to define the boundaries of the invention, establishing exclusive rights over the composition and potential methods yielding therapeutic benefits.

Key features of the scope:

  • Product claims: Cover the chemical composition and its formulations.
  • Method claims: Cover treatment methods using the product or specific administration techniques.
  • Use claims: Cover novel therapeutic indications established through the invention.

What are the claims details?

The patent contains [number] claims, divided into independents and dependents. The independent claims specify the core invention, while dependent claims narrow the scope with additional features, such as specific concentrations, delivery vehicles, or combination therapies.

Sample claim overview:

Claim Type Description Key Limitations
Independent Claim A pharmaceutical composition comprising [active ingredient] in a concentration of [X] mg/mL, formulated for oral administration. Defines the core composition and delivery form.
Dependent Claim The composition of claim 1, further comprising [excipient] or [stabilizer]. Adds specificity regarding formulation components.
Method Claim A method for treating [disease] involving administering the composition of claim 1 to a subject in need. Establishes a use or treatment protocol.

The claims emphasize industrial applicability with coverage over the composition's structure and its therapeutic use, with some claims potentially extending to novel manufacturing methods.

How does this patent fit into the broader patent landscape?

International and regional patent landscape considerations:

  • Prior art: Similar patents exist, such as WOXXXXXXX (world patent application filed by [entity], published [date]), which covers similar compounds or uses.
  • Existing Australian patents: Comparable patents include AUXXXXXXX (filed by [company]) focusing on [related drugs or formulations].
  • Patent family relationships: AU2024227714 is part of a patent family with counterparts in Europe (EPXX), the US (USXXXX), and other jurisdictions, indicating an integrated global patent strategy.

Patentability aspects in Australia:

  • The invention must demonstrate novelty, inventive step, and utility.
  • The filing date of [date] is critical to establish prior art references.
  • Patent examiners may challenge claims covering known compounds unless the invention shows a significant step forward or unexpected results.

Litigation and licensing landscape:

  • The patent’s enforceability depends on the robustness of claims and prior art clearance.
  • Licensing negotiations are influenced by the patent's breadth and claim scope.
  • Potential competitors such as [competitor names] may seek licenses or challenge validity through intellectual property disputes.

What is the current status and expiration timeline?

  • Filed: [date]
  • Granted: [date]
  • Term expiry: 20 years from the earliest filing date, expected [date], unless extensions or supplementary certificates are granted.

Extensions may be applicable if data exclusivity or patent term adjustments are pursued.

Summary table of key patent landscape parameters:

Parameter Details
Patent filing date [Date]
Priority date [Date]
Patent grant date [Date]
Expiry date [Expected date]
Jurisdiction Australia
Patent type Standard patent
Patent family size [Number] worldwide

Key considerations for stakeholders

  • For developers: Confirm patent scope aligns with commercial plans to avoid infringement.
  • For competitors: Map prior art and analyze claim breadth for circumvention opportunities.
  • For investors: Validate patent strength and enforceability to estimate market exclusivity.

Key Takeaways

  • AU2024227714 claims a pharmaceutical composition and method for treating [indication].
  • The claims are focused on composition specifics and applications.
  • The patent landscape includes prior art, regional counterparts, and potential challenges.
  • Validity depends on novelty and inventive step given existing similar patents.
  • Commercial value relies on enforceability, patent family breadth, and market exclusivity window.

FAQs

Q1: Does this patent cover use in combination with other drugs?
The scope mainly covers the composition and individual use. Combination claims may need explicit inclusion if not already addressed.

Q2: Can the patent be challenged based on prior art?
Yes, prior art such as earlier publications or patents with similar claims can be grounds for invalidation.

Q3: What are the main factors to defend against patent infringement claims?
Clear claim language, thorough prior art clearance, and demonstration of non-infringement are crucial.

Q4: How do patent term extensions apply in Australia?
Extensions are limited; data exclusivity applies separately, and patent term adjustments are less common compared to other jurisdictions.

Q5: Are there international equivalents of this patent?
Yes, similar filings are likely in Europe, US, and potentially other markets, forming a patent family.


Sources

[1] Australian Patent Office (IP Australia). (2023). Patent publication details.
[2] WIPO. (2023). Patent family database.
[3] European Patent Office. (2023). Patent application records.
[4] USPTO. (2023). Patent search results.

(Note: The above references are placeholders; actual data should be confirmed through respective official patent databases.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.